Asian Market Big for Orthobiologics

The writers in Digital Journal are predicting that the orthobiologics market in Asia will grow to around $703.9 million by 2018. Orthobiologics are substances that orthopedic surgeons use to help injuries heal more quickly. They use them to improve the healing of broken bones and injured muscles, tendons, and ligaments. Most biologics are made from substances that are naturally found in the human body.

The growth of the Asian orthopedic devices and orthobiologics market is driven by the fact that the growing middle class in that region now has more money to spend on conditions requiring orthopedic services. The mindset of the residents is also changing. They are more aware of alternative desirable lifestyles and, when undergoing surgery, know to ask for less invasive procedures that lead to less pain, less scarring and shorter hospital stays.

According to PRWeb, the major consumers of the orthobiologics are ageing patients who have hip and knee joint replacement surgery and spinal surgery. Next are victims of auto accidents and sports injuries. PRWeb reports that the devices used in Asia are both of advanced design and less expensive than those used in the U.S. and Europe. The major markets in the region are China, Japan and India, with Japan leading as the largest market for both orthopedic and orthobiologics. In 2014 Japan accounts for 40% of the Asian market.